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Abstract-Rat pleurisy was induced by an intrapleural injection of 1 nmol (0.1 ml) of phorbol myristate acetate (PMA). Accumulation of pleural fluid peaked at a volume of 1 ml at 1 hr, and exudation rate peaked at 30 min when measured by the amount of dye leaked into the pleural cavity during 20 min. Histamine contents decreased in the pleural cell pellets markedly at 30 min and increased in the super natant fluid simultaneously, reflecting histamine release that occurred in 30 min after PMA. Pretreatment with mepyramine maleate or methysergide 30 min prior to the PMA-injection suppressed the fluid volume significantly.
The result indicates that there are involvements of 5-hydroxytryptamine and the H1 -receptor of histamine in the vascular permeability increase at the early stage of PMA-pleurisy.
Experimental rat pleurisy has been reported by many workers (1-3) and proved to be a good tool for the search for mediators of acute inflammation. We also previously reported rat pleurisy induced by carrageenin and demon strated the involvements of the plasma kinin system and PGE2 in the pleural fluid ac cumulation in 3 hr after the carrageenin injection (4).
The pleurisy induced by croton-oil was also previously reported, showing different characteristics from carrageenin pleurisy in that the former was not inhibited by bromelain, a plasma kinin system depleter, but was partially inhibited by indomethacin and markedly inhibited by dexamethasone, suggesting that the kinin system did not participate in this pleurisy, but suggests that other mediators were involved (5) .
In this report, we examined the involvement of histamine in the rat pleurisy induced by intrapleural injection of phorbol myristate acetate (PMA), one of the active com ponents in croton oil, since the preliminary experiment with croton oil-pleurisy showed the possibility of involvement of histamine in the early phase. Rat pleurisy: Pleurisy was induced by an intrapleural injection of 0.1 ml of 1 % croton oil suspension in saline or 1 nmol PMA in 0.1 ml saline solution into a rat under light ether anesthesia as previously described (4, 5) . At 0.5, 1, 2, 3, 5 and 7 hr after PMA injection, rats were exsanguinated from carotid artery through polyethylene cannula (PE 60). After complete exsanguination, the pleural cavity was opened and pleural fluid was collected into a plastic syringe (Terumo , Tokyo) and stored in a polyethylene tube containing 1/10 volume of 3.8% sodium citrate. The cavity was then washed with 1 ml of 0.9% saline, and the wash was also collected with 1 /10 volume of sodium citrate.
Materials and Methods

Animals
Pontamine sky blue solution (50 mg/ml of 0.45% saline, 60 mg/kg) was injected into the tail vein 20 min before the sacrifice to estimate the exudation rate, as described before (6) .
Pleural cells in the collected samples were counted by a Sysmex platelet counter (PL 110, Toa Electric Co.). Red blood cells and white cells in peripheral blood were also counted. Films of peripheral blood and pleural fluid were stained with Giemsa, and a differential cell count was performed under the light microscope.
Histamine assay: For the series of in vitro experiments, the rat pleural cavity was washed with Ca", Mg"-free HEPES-buffered Hanks' balanced salt solution (HBSS), without injection of pontamine sky blue. Collected pleural wash fluid (3 ml) was centrifuged at 400 g for 10 min at O'C, and the supernatant solution and the precipitate were assayed for histamine. The resuspended precipitate (3 ml of the same buffer) and the supernatant were added with 1.5 ml of 2N hydroperchloric acid solution for deproteinization.
Each sample was centrifuged at 2100 g for 20 min at 0°C , and the supernatant solution was mixed with 1 ml of 4N KOH and centrifuged at 2100 g for 10 min at 0°C. Histamine in the super natant solution was assayed by the method described by Shore (6) . The intensity of fluorescence was measured by a fluorescence spectrophotometer (Hitachi, 650-10M), and a linear standard curve of 5-500 ng/ml histamine was obtained. Recovery % throughout the extraction procedure was about 60% from the collection of the pleural cavity wash. 
Results
Croton oil induced pleurisy: Croton oil induced rat pleurisy was previously described as the peak fluid accumulation was observed at 16 hr (5) . Involvement of histamine in the early phase of vascular permeability increase was examined by pretreatment with 5 mg/kg mepyramine maleate, intraperitoneally, 30 min before the inciter. As shown in Table 1 , mepyramine suppressed both the fluid ac cumulation and exudation rate at 1 and 3 hr after croton oil injection.
Histamine content in the pleural fluid was measured by Shore's method (6), as shown in Table 2 . The results showed that the pleural wash of the intact animals contained a large amount of histamine in cellular pellets, but the pleural fluid of 1 hr after the inciter contained a slight amount of histamine in cellular pellets and a higher level in the supernatant solution, reflecting a release of histamine from pleural cells by croton oil. In the pleural fluid of 3 hr, there was less histamine even in the supernatant as well as in the cell pellets, and this may suggest that catabolism or excretion of the released histamine might occur in the pleural cavity. 
PMA-pleurisy:
The time course of rat pleurisy induced by 1 nmol PMA is shown in Fig. 1 . The time course of the fluid ac cumulation, exudation rate and pleural cell count are shown in Fig. 1 Table 3 . The percentage of mast cells in the pleural wash of intact animals was about 10-12%, but it decreased at 0.5-1 hr after the in citer and was approximately 4-5% including those partially degranulated.
At the early stage of pleurisy when the vascular perme ability increase showed a peak, the major cell population in the cavity was mononuclear cells, and the number of polymorphonuclear leukocytes was about 2% at 0.5 hr and these cells gradually increased in number to 65% of the total cells at 5 hr.
Histamine contents in the supernatant of pleural fluid and the cell pellets were measured as shown in Fig. 2 The effects of some pretreatments are illustrated in Fig. 3 . All agents were injected intraperitoneally into rats 30 min before the inciter. Mepyramine maleate, 5 mg/kg, and methysergide, 1 mg/kg, suppressed the fluid accumulation and exudation rate sig nificantly. Cimetidine, 100 mg/kg, had no effect, but the number of the pleural total cells was increased. At 1 hr, the effects of mepyramine and cimetidine were significant, but methysergide had no significant effect, and furthermore, these agents did not affect the cell number.
The mechanism of sup pression by cimetidine at 1 hr is not known. In vitro study:
The cells were collected from the pleural cavities of the normal rats and incubated with PMA in vitro. The time course of the histamine release is shown in Fig. 4A . The data express the means of 3 experiments with 100 nM PMA. The release took place continuously over the period of 120 min. The dose-response curve of histamine release from the pleural cell mixture by PMA is illustrated in Fig. 4B , showing the value of the means of 3 experi ments with an overall standard deviation of 8.6%. Peak release was around 75 nM, and no lactate dehydrogenase (LDH) release over the basal amount accompanied the hista mine release. The result agreed with the report of Schleimer et al. (7), as histamine release by PMA may not be cytotoxic. Table 4 . The inhibitory effect of BPB was dose-dependent, but other agents had no significant effect, suggesting that there may be partial involvement of arachidonic acid metabolites in the histamine release.
Discussion
From the result of croton oil-induced pleurisy, it was concluded that there was an involvement of histamine in the early phase of vascular permeability increase in this inflammation model. Although the pretreat ment with mepyramine suppressed the pleural fluid accumulation, the amounts of histamine release of mepyramine-treated animals were larger than those of the controls at 1 and 3 hr after croton oil ( Table 2 ). The reason in not known, but one could suppose there might be an unknown autoregulatory mechanism for histamine release by histamine itself.
Anti-inflammatory effects of mepyramine and methysergide have been reported as limited in some inflammatory models, such as thermal injury or carrageenin edema (8) , when used in doses proved as effectively antagonize the amines. The doses of these antagonists used here would be enough to antagonize the effect of each amine (9, 10) , and the pleurisy induced by PMA may be a model where these amines have roles, since PMA has been proven to release histamine and 5 HT in vitro and in vivo to increase vascular permeability. PMA is a component of croton oil which has been used to induce an inflammatory model, and PMA could be the active pro-inflammatory substance in the oil to induce vascular permeability increase (5) . The effects of anti-histamine drugs, mepyramine and cimetidine, and me thysergide, suggest that H, receptors of histamine and 5-hydroxytryptamine may be the main receptors to induce vascular permeability increase in this pleurisy at 30 min.
The fact that N DGA at 10-4 M partially inhibited pleural cells to releasae histamine by PMA suggests that the effect may not be specific. However, the fact that BPB showed an inhibitory effect as cited in Table 3 suggests that there may be partial involvement of a lipoxygenase product in histamine relaese of the pleural cells by PMA. More work is necessary to make conclusions about the above result, since BPB is not a specific inhibitor of phospholipase A2 or lipoxygenase.
